BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 18591919)

  • 1. Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities?
    Wilson MG; Chandra N; Papadakis M; O'Hanlon R; Prasad SK; Sharma S
    J Cardiovasc Magn Reson; 2011 Nov; 13(1):77. PubMed ID: 22122802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Order from disorder in the sarcomere: FATZ forms a fuzzy but tight complex and phase-separated condensates with α-actinin.
    Sponga A; Arolas JL; Schwarz TC; Jeffries CM; Rodriguez Chamorro A; Kostan J; Ghisleni A; Drepper F; Polyansky A; De Almeida Ribeiro E; Pedron M; Zawadzka-Kazimierczuk A; Mlynek G; Peterbauer T; Doto P; Schreiner C; Hollerl E; Mateos B; Geist L; Faulkner G; Kozminski W; Svergun DI; Warscheid B; Zagrovic B; Gautel M; Konrat R; Djinović-Carugo K
    Sci Adv; 2021 May; 7(22):. PubMed ID: 34049882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy.
    Eden M; Frey N
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33557094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of
    Auxerre-Plantié E; Nielsen T; Grunert M; Olejniczak O; Perrot A; Özcelik C; Harries D; Matinmehr F; Dos Remedios C; Mühlfeld C; Kraft T; Bodmer R; Vogler G; Sperling SR
    Dis Model Mech; 2020 Dec; 13(12):. PubMed ID: 33033063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Characterization of Long Noncoding RNAs in Ovine Skeletal Muscle.
    Li Q; Liu R; Zhao H; Di R; Lu Z; Liu E; Wang Y; Chu M; Wei C
    Animals (Basel); 2018 Jul; 8(7):. PubMed ID: 30041440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands.
    Christiaans I; Nannenberg EA; Dooijes D; Jongbloed RJ; Michels M; Postema PG; Majoor-Krakauer D; van den Wijngaard A; Mannens MM; van Tintelen JP; van Langen IM; Wilde AA
    Neth Heart J; 2010 May; 18(5):248-54. PubMed ID: 20505798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.
    Tardiff JC
    Heart Fail Rev; 2005 Sep; 10(3):237-48. PubMed ID: 16416046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
    Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
    Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy.
    Osio A; Tan L; Chen SN; Lombardi R; Nagueh SF; Shete S; Roberts R; Willerson JT; Marian AJ
    Circ Res; 2007 Mar; 100(6):766-8. PubMed ID: 17347475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.
    Guo X; Fan C; Wang Y; Wang M; Cai C; Yang Y; Zhao S; Duan F; Li Y
    Medicine (Baltimore); 2017 Mar; 96(11):e6249. PubMed ID: 28296734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity.
    Ruggiero A; Chen SN; Lombardi R; Rodriguez G; Marian AJ
    Cardiovasc Res; 2013 Jan; 97(1):44-54. PubMed ID: 22987565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy.
    Posch MG; Thiemann L; Tomasov P; Veselka J; Cardim N; Garcia-Castro M; Coto E; Perrot A; Geier C; Dietz R; Haverkamp W; Ozcelik C
    Med Sci Monit; 2008 Jul; 14(7):CR372-4. PubMed ID: 18591919
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.